Mechanistic insights link its activity to Rac1 stimulation, Rho attenuation, and PIK3CD amplification [59, 61], with further implications in tumor–stroma interplay impacting pancreatic cancer resilience and expansion [62]. The gene discussed is RAC1; the disease is neoplasm.